ORP-103

N/A

Report date: 2025/01/26 17:31:53
NME

Base Information

Drug NameORP-103
Drug Alias Nameserotonin modulator/norepinephrine modulator (OrphoMed)ORP-103
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin (5-HT) receptor modulators
TargetsSerotonin (5-HT) receptor
Therapy Area/IndicationsGastrointestinal motility disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOrphomed Inc
China Registration ClassN/A

Develop Information

Active CompaniesOrphomed Inc
Inactive CompaniesN/A
Active IndicationsGastrointestinal motility disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A